Literature DB >> 18809934

Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.

Sabrina Schubert1, P David Rogers, Joachim Morschhäuser.   

Abstract

Candida dubliniensis, a yeast that is closely related to Candida albicans, can rapidly develop resistance to the commonly used antifungal agent fluconazole in vitro and in vivo during antimycotic therapy. Fluconazole resistance in C. dubliniensis is usually caused by constitutive overexpression of the MDR1 gene, which encodes a multidrug efflux pump of the major facilitator superfamily. The zinc cluster transcription factor Mrr1p has recently been shown to control MDR1 expression in C. albicans in response to inducing stimuli, and gain-of-function mutations in the MRR1 gene result in constitutive upregulation of the MDR1 efflux pump. We identified a gene with a high degree of similarity to C. albicans MRR1 (CaMRR1) in the C. dubliniensis genome sequence. When C. dubliniensis MRR1 (CdMRR1) was expressed in C. albicans mrr1Delta mutants, it restored benomyl-inducible MDR1 expression, demonstrating that CdMRR1 is the ortholog of CaMRR1. To investigate whether MDR1 overexpression in C. dubliniensis is caused by mutations in MRR1, we sequenced the MRR1 alleles from a fluconazole-resistant, clinical C. dubliniensis isolate and a matched, fluconazole-susceptible isolate from the same patient as well as those from four in vitro-generated, fluconazole-resistant C. dubliniensis strains derived from two different C. dubliniensis isolates. We found that all five resistant strains contained single nucleotide substitutions or small in-frame deletions that resulted in amino acid changes in Mrr1p. Expression of these mutated alleles in C. albicans resulted in the constitutive activation of the MDR1 promoter and multidrug resistance. Therefore, mutations in MRR1 are the major cause of MDR1 upregulation in both C. albicans and C. dubliniensis, demonstrating that the transcription factor Mrr1p plays a central role in the development of drug resistance in these human fungal pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809934      PMCID: PMC2592883          DOI: 10.1128/AAC.00740-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans.

Authors:  K Fekete-Forgács; L Gyüre; B Lenkey
Journal:  Mycoses       Date:  2000-09       Impact factor: 4.377

2.  Antifungal resistance in pathogenic fungi.

Authors:  Sofia Perea; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2002-11-01       Impact factor: 9.079

3.  Evolution of drug resistance in experimental populations of Candida albicans.

Authors:  L E Cowen; D Sanglard; D Calabrese; C Sirjusingh; J B Anderson; L M Kohn
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

4.  Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters.

Authors:  Mahir Karababa; Alix T Coste; Bénédicte Rognon; Jacques Bille; Dominique Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

Review 5.  Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.

Authors:  Derek J Sullivan; Gary P Moran; Emmanuelle Pinjon; Asmaa Al-Mosaid; Cheryl Stokes; Claire Vaughan; David C Coleman
Journal:  FEMS Yeast Res       Date:  2004-01       Impact factor: 2.796

6.  Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensis.

Authors:  Gary Moran; Cheryl Stokes; Sascha Thewes; Bernhard Hube; David C Coleman; Derek Sullivan
Journal:  Microbiology (Reading)       Date:  2004-10       Impact factor: 2.777

7.  The SAT1 flipper, an optimized tool for gene disruption in Candida albicans.

Authors:  Oliver Reuss; Ashild Vik; Roberto Kolter; Joachim Morschhäuser
Journal:  Gene       Date:  2004-10-27       Impact factor: 3.688

8.  Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.

Authors:  L Millon; A Manteaux; G Reboux; C Drobacheff; M Monod; T Barale; Y Michel-Briand
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

9.  The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.

Authors:  Gary Moran; Derek Sullivan; Joachim Morschhäuser; David Coleman
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

10.  Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations.

Authors:  A M Gillum; E Y Tsay; D R Kirsch
Journal:  Mol Gen Genet       Date:  1984
View more
  25 in total

1.  Transcriptional profiling of azole-resistant Candida parapsilosis strains.

Authors:  A P Silva; I M Miranda; A Guida; J Synnott; R Rocha; R Silva; A Amorim; C Pina-Vaz; G Butler; A G Rodrigues
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Modeling the transcriptional regulatory network that controls the early hypoxic response in Candida albicans.

Authors:  Adnane Sellam; Marco van het Hoog; Faiza Tebbji; Cécile Beaurepaire; Malcolm Whiteway; André Nantel
Journal:  Eukaryot Cell       Date:  2014-03-28

3.  Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors.

Authors:  Sabrina Schneider; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

Review 4.  The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen.

Authors:  Joachim Morschhäuser
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

5.  Inducible and constitutive activation of two polymorphic promoter alleles of the Candida albicans multidrug efflux pump MDR1.

Authors:  Christoph Sasse; Rebecca Schillig; Alexandra Reimund; Julia Merk; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

6.  Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.

Authors:  Jamel Eddouzi; Josie E Parker; Luis A Vale-Silva; Alix Coste; Françoise Ischer; Steve Kelly; Mohamed Manai; Dominique Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

7.  Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system.

Authors:  Nina T Grossman; Cau D Pham; Angela A Cleveland; Shawn R Lockhart
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

8.  Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1.

Authors:  Sabrina Schubert; Christina Popp; P David Rogers; Joachim Morschhäuser
Journal:  Eukaryot Cell       Date:  2011-06-17

9.  Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.

Authors:  Christina Popp; Irene A I Hampe; Tobias Hertlein; Knut Ohlsen; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

10.  SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1.

Authors:  Bernardo Ramírez-Zavala; Selene Mogavero; Eva Schöller; Christoph Sasse; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.